NeuroAI NEUROAINEUROAI.SITE
ESC

Unitree's Series C values the Hangzhou robot maker near US$1.7B — and looks like an IPO rehearsal

Unitree Robotics, the Hangzhou company behind the G1 and H1 humanoid robots, closed a Series C in 2025 that values it around RMB 12 billion (≈ US$1.7 billion / HK$13 billion). The round was led by China Mobile, Tencent, Alibaba, Ant and Geely — and the company quietly turned itself into a joint-stock firm, the classic first step toward an IPO.

2026-09-28 · 807 words · NeuroAI
Unitree's Series C values the Hangzhou robot maker near US$1.7B — and looks like an IPO rehearsal

A humanoid robot that dances at the Spring Festival Gala just became a balance-sheet event. Unitree, the Hangzhou builder of cheap, capable legged machines, closed a funding round that values it like a serious hardware company — not a lab experiment.

The tell was not the money. It was the paperwork.

The round, in numbers

Unitree completed its Series C in mid-2025, a round that had opened in late 2024. The verified figures:

  • Valuation: about RMB 12 billion (≈ US$1.7 billion / HK$13 billion) post-money; pre-money was already above RMB 10 billion.
  • Round size: reported at around RMB 700 million (≈ US$98 million / HK$770 million) — Unitree disclosed the valuation but not the exact amount, so this is a market estimate.
  • Lead investors: China Mobile's investment fund, Tencent, HongShan (锦秋), Alibaba, Ant Group and Geely Capital, with most earlier backers following on.
  • Registered capital jumped to RMB 3.64 billion (≈ US$510 million / HK$4 billion) in June 2025.

Founder and CEO Wang Xingxing (王兴兴), born in 1990, started the company alone in 2016. It now employs more than 1,000 people and, by his own statement at the 2025 Summer Davos forum, passed RMB 1 billion (≈ US$140 million / HK$1.1 billion) in annual revenue.

Why the restructuring matters

On 29 May 2025, the firm changed its name from "Hangzhou Unitree Technology Co." to "Hangzhou Unitree Technology Co., Ltd. (股份有限公司)" — a joint-stock company. Two weeks later its registered capital leapt 125-fold.

In China, that corporate form is the doorway to a public listing. Multiple outlets reported that Unitree and its investors are pushing toward an IPO, with the A-share market the first choice and Hong Kong a fallback. Nobody has filed a prospectus, and the company has not confirmed a date. But the sequence — raise, restructure, hint — is the oldest script in Chinese tech.

What Unitree actually sells

Unlike most humanoid (人形机器人) startups, Unitree ships product today.

  • The Go2 quadruped (四足机器人) starts under US$2,000 and is a default research platform worldwide.
  • The G1 humanoid lists at about US$16,000 — a fraction of what rivals charge.
  • The H1 is its "first universal humanoid robot," with over-the-air software updates.

Unitree's edge is price. Its robots run up to 50% cheaper than comparable systems, which is why universities and R&D labs — not just show stages — buy them. An industry report cited by Chinese media puts Unitree's share of global quadruped (四足机器人) sales at roughly 70% in 2023, a dominance that explains why strategic investors, not just VCs, showed up.

The risks behind the valuation

Two cautions are worth stating plainly.

First, the round size is an estimate. Unitree confirmed the valuation and the investor list but not the dollar amount; the RMB 700 million figure comes from Beijing Daily and industry estimates, not a company disclosure.

Second, humanoid (人形机器人) revenue is still young. Wang himself has said large-scale deployments have not happened yet. The Gala performances are great theatre, but they are choreography, not proof of autonomous work in a warehouse. The valuation prices the future, not the floor.

What readers can do now

  • If you buy or build robotics: Unitree's sub-US$20,000 humanoids are the volume play. Benchmark a G1 on a real task before assuming a pricier US or European humanoid is "more capable."
  • If you follow listings: watch for a formal IPO filing. The joint-stock conversion is the signal; a prospectus is the proof. Until then, "preparing for an IPO" is not "going public."
  • If you invest: separate valuation (RMB 12B / ≈ US$1.7B, verified) from round size (≈ RMB 700M / US$98M, estimated). The first is disclosed; the second is reported.

Honest limitations

Core facts — Series C closed mid-2025, ~RMB 12B (≈ US$1.7B) post-money valuation, pre-money above RMB 10B, China Mobile fund/Tencent/Alibaba/Ant/Geely/HongShan lead, joint-stock conversion on 29 May 2025, registered capital RMB 3.64B (≈ US$510M) on 18 June 2025, founder Wang Xingxing, 2016 founding, ~RMB 1B (≈ US$140M) annual revenue stated at 2025 Summer Davos, G1 at ~US$16,000, Go2 under US$2,000 — come from Beijing Daily (北京日报, 26 June 2025), The Robot Report (2025), Chinatimes/工商時報 (21 June 2025), Sina/长江商报 (23 June 2025), and Baidu Baike. The RMB 700M (≈ US$98M / HK$770M) round size is reported by Beijing Daily and The Robot Report ("some estimates put the round at US$97.6M") but was not officially disclosed by Unitree; treat as an estimate. The ~70% 2023 global quadruped share is cited by Chinese media attributing GGII (高工机器人产业研究所) and is an industry estimate. The IPO plan (A-share preferred, HKEX fallback) is reported but unconfirmed by Unitree; no filing or date exists. Currency: RMB 12B ÷ 7.1 ≈ US$1.7B, × 7.8 ≈ HK$13B; RMB 700M ≈ US$98M / HK$770M; RMB 1B ≈ US$140M / HK$1.1B; RMB 3.64B ≈ US$510M / HK$4B. Conversions approximate. Not investment advice. Current to 28 September 2026.

Related coverage

More in “Capital & Markets” → · Back to home · Markdown version